Canopy Growth Cannabis Stock Shares Plunge After Another Net Loss
Canopy Growth Corp (WEED.TO), posted another core loss on Friday, denting investor hopes that the cannabis producer would turn profitable anytime soon, sending its U.S.-listed shares down 10%.
The company’s quarterly gross margin was impacted by a decline in production, lower prices in the Canadian recreational business, a shift in business mix and fall in government payroll subsidies related to COVID-19 relief program.
Canopy has been focusing on premium high-potency offerings and has undertaken cost cuts through layoffs, exits from some international markets and store closures in its bid to turn profitable, after nearly four years of cannabis legalization in Canada.
“We expect cost savings to ramp in the second half of the year,” Chief Financial Officer Judy Hong said in a statement.
Canopy earlier this year extended its time frame to achieve profitability as fewer-than-expected retail stores and cheaper black market rates crimp sales at legal recreational companies.
The company, which had first aimed to turn profitable by the second half of 2022, now expects to turn in positive earnings before interest, taxes, depreciation, and amortization in fiscal 2024, excluding certain investments. Analysts estimate it will be delayed by another year.
The cannabis producer also took a hit of C$1.73 billion ($1.34 billion) in the quarter due to asset impairment charges and restructuring costs, forcing it to post a net loss from year-ago profit.
Canopy Growth, which operates primarily in Canada that accounts for roughly 50% of its sales, said revenue fell 19% to C$110 million in the quarter ended June.
The company posted an adjusted core loss of C$74.8 million in the first quarter ended June 30.
Canopy Growth Cannabis Stock Shares Plunge After Another Net Loss
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
